Global Immunodiagnostics Market accounted for US$ 19.30 billion in 2020 and is estimated to be US$ 39.69 billion by 2030 and is anticipated to register a CAGR of 7.50%. Immunodiagnostics is a subfield of in-vitro diagnostics that deals with the diagnosis of various diseases based on antigen antibody responses. It is a primary method for identifying infectious diseases, chronic diseases such as cancer and cardiovascular disease, autoimmune diseases, and endocrinology, among other things. Significant advancements in immunodiagnostics technology have improved the ability to target specific areas for disease progression diagnosis. The advancement of technology has aided in the detection of complex disorders. The immunodiagnostics market is divided into three categories depending on product type: reagents, instruments, and software and services. Infectious diseases have a significant market share in the global immunodiagnostics market and are likely to continue this position throughout the study period.
Increased demand for activated alumina in water treatment industries is projected to drive the global market. The rise in incidences of infectious diseases (HIV, STI, hepatitis B, and others), cardiovascular diseases, cancer, gastrointestinal, and other chronic diseases around the world as a result of an ageing population and changes in demographics and lifestyle are the major factors driving the immunodiagnostics market’s growth. Furthermore, technical advancements in diagnosis kits, assays, and analyzers, as well as increased awareness of preventive health measures among patients and medical professionals, generate demand for immunodiagnostics goods, driving growth. However, a number of obstacles are predicted to hinder market growth. The impact of the drivers is projected to be greater than the impact of the constraints.
Download free sample copy of this report @
Key Highlights of Immunodiagnostics Market:
Mesa Biotech, a private point-of-care molecular diagnostic startup, was bought by Thermo Fisher Scientific Inc. in February 2021.
Abbott got the CE Mark for their Panbio COVID-19 Ag Rapid Test Device for the asymptomatic detection of the SARS-CoV-2 virus in January 2021. It also has self-swabbing capabilities.
Beckman Coulter, a Danaher (US) business, will launch the first high-quality and throughput assay for COVID-19 antigen diagnosis, named Access SARS-CoV-2 Antigen assay, in the US in December 2020.
Thermo Fisher Scientific will introduce its EliA SARS-CoV-2-Sp1 IgG test and OmniPATH COVID-19 Total Antibody ELISA test for the detection of COVID-19 antibodies in October 2020.
Key Market Insights from the report:
Global Immunodiagnostics Market accounted for US$ 19.30 billion in 2020 and is estimated to be US$ 39.69 billion by 2030 and is anticipated to register a CAGR of 7.50%. The Global Immunodiagnostics Market report segments the market on the basis of type, technology, application and region.
Immunodiagnostic Instruments, Immunoassays
Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test and Others
Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing, GI Stool Testing
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape & their strategies of Immunodiagnostics Market:
The key players operating in the Global Immunodiagnostics Market includes BASF SE (Germany), Sumitomo Chemical Co., Ltd. (Japan), Honeywell International, Inc. (U.S.), J.M. Huber Corporation (U.S.), Porocel Corporation (U.S.), AGC Chemicals Pvt. Ltd. (India), Axens SA (France), Dynamic Adsorbents, Inc. (U.S.), Sorbead India (India), and Camfil Group (Sweden). The competition is primarily driven by the application scope and use of activated alumina in a different type of products.
Ask for discount@
Global Immunodiagnostics Market, By Type:
Global Immunodiagnostics Market, By Technology:
Enzyme-Linked Immunosorbent Assay
Global Immunodiagnostics Market, By Application:
Oncology and Endocrinology
Hepatitis and Retrovirus Testing
Infectious Disease Testing
GI Stool Testing
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
Some Important Points Answered in this Market Report Are Given Below:
Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
Immunoglobulin Market, By Product (IgG, IgA, IgM, IgE, and IgD), By Mode of Delivery (Intravenous and Subcutaneous), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Trends, Analysis and Forecast till 2030
Global Immuno-Oncology Drugs Market By Drugs Type (Immune Checkpoint Inhibitors (CTL-4 Checkpoint Inhibitor and PD-1 & PD-L1 Checkpoint Inhibitor), Monoclonal Antibodies, Cytokine Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, By Cancer Type (Non-Small Cell Lung Cancer, Acute Myeloid Leukemia, Lymphoma (Hodgkin’s and Non-Hodgkin’s Lymphoma), Multiple Myeloma, Breast Cancer, Ovarian Cancer, Prostate Cancer, Colorectal Cancer, Gastric Cancers, Glioblastoma, Head & Neck Cancers), By Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Trends, Analysis and Forecast till 2029
Market Dynamics, Regulations, and Trends Analysis
DR Impact Analysis
Porter’s Five Forces Analysis
Market Investment Feasibility Index
Macroeconomic Factor Analysis
Market Breakdown and Data Triangulation
Approach for estimating Market Share by Top-Down Analysis (Supply Side)
Approach for estimating market share by Bottom-up Analysis (Demand Side)
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
Company Name: Prophecy Market Insights
Contact Person: Sidhant
Email: Send Email
Phone: +1 8605312701
Address:964 E. Badillo Street #2042 Covina, CA 91724
Country: United States